OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(30)
Publication Date
Release Date
2022
(4)
2010
(4)
2024
(3)
2023
(3)
2021
(3)
2018
(2)
2015
(2)
2014
(2)
2012
(2)
2011
(2)
2025
(1)
2016
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.
Not available
S-EPMC3295548
|
biostudies-literature
Cite
[
123
I]MIBG is a better early marker of anthracycline cardiotoxicity than [
18
F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study.
Not available
S-EPMC8452816
|
biostudies-literature
Cite
Social factors, health policy, and environment: implications for cardiovascular disease across the globe.
Not available
S-EPMC12342468
|
biostudies-literature
Cite
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
Not available
S-EPMC4178524
|
biostudies-literature
Cite
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo.
Not available
S-EPMC6301908
|
biostudies-literature
Cite
Quantifying Population Burden and Effectiveness of Decentralized Surveillance Strategies for Skin-Presenting Neglected Tropical Diseases, Liberia.
Not available
S-EPMC9423900
|
biostudies-literature
Cite
Simvastatin in Critically Ill Patients with Covid-19.
Not available
S-EPMC10755839
|
biostudies-literature
Cite
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.
Not available
S-EPMC3446398
|
biostudies-literature
Cite
The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.
Not available
S-EPMC11635535
|
biostudies-literature
Cite
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
Not available
S-EPMC3111069
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets